MedTrace Logo

A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden

NCT03903094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6295279

Last updated 2024-10-31

No results posted yet for this study

Summary

Outpatients with at least one dispensing record of any medication will be included in the study. An index date will be assigned to each participant and prescription records for anticholinergics will be used in the study.

Conditions

  • Overactive Bladder (OAB)

Interventions

OTHER

Non-Interventional

Overview of anticholinergic burden, rather than to evaluate specific drugs

Sponsors & Collaborators

  • Astellas Pharma Singapore Pte. Ltd.

    lead INDUSTRY

Principal Investigators

  • Central Contact · Astellas Pharma Global Development, Inc.

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-07
Primary Completion
2022-05-06
Completion
2022-05-06

Countries

  • Australia
  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903094 on ClinicalTrials.gov